• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

简易认知测试 PDD-Short Screen:用于帕金森病患者痴呆筛查的简易认知测试。

PDD-Short Screen: a brief cognitive test for screening dementia in Parkinson's disease.

机构信息

Movement Disorders Unit, Neurology Department, Sant Pau Hospital, Autonomous University of Barcelona, Barcelona, Spain.

出版信息

Mov Disord. 2010 Mar 15;25(4):440-6. doi: 10.1002/mds.22877.

DOI:10.1002/mds.22877
PMID:20155863
Abstract

The diagnosis of Parkinson's disease with dementia (PDD) is currently based on clinical criteria (DSM-IV, MDS-Task Force). In daily practice and research studies, these criteria still depend on the subjective impression of the examiner. Brief screening tests (BST) are helpful in identifying patients with PD with dementia, which can be difficult in patients with advanced PD. We aimed to develop a BST for PD, the PDD-Short Screen (PDD-SS), to accurately and quickly screen for PDD. In this prospective study, 70 patients with nondemented (age 73.8 +/- 4.4) and 32 demented (age 73.8 +/- 4.4) PD regularly attending a Movement Disorders Clinic were included. Diagnosis of dementia was based on DSM-IV criteria, CDR score >or=1, and PD-CRS total score <or=64. The PDD-SS, Mattis Dementia Rating Scale (MDRS), and Mini-Mental State Examination (MMSE) were administered to all participants. Validity, reliability, and discriminative power of the PDD-SS were examined. The final version of the scale included the items immediate and delayed verbal memory, clock drawing, alternating verbal fluency, and a questionnaire covering cognitive and psychiatric (hallucinations, apathy) symptoms common in PDD. A cutoff score <or=11 on the PDD-SS yielded high sensitivity (89.8%) and specificity (88.5%) for diagnosing PDD. The MDRS displayed similar accuracy, but the PDD-SS administration time was significantly shorter (4.8-6.9 vs. 17.5-25.2 minutes). Diagnosis of dementia using the PDD-SS was not influenced by age, education, or motor function. The PDD-SS appears as the first BST for diagnosing PDD, displays an excellent diagnostic accuracy, and takes 5 to 7 minutes to be administered.

摘要

帕金森病伴痴呆(PDD)的诊断目前基于临床标准(DSM-IV、MDS-工作组)。在日常实践和研究中,这些标准仍然依赖于检查者的主观印象。简短的筛查测试(BST)有助于识别患有痴呆的 PD 患者,但在晚期 PD 患者中可能会很困难。我们旨在开发一种用于 PD 的 BST,即 PDD-Short Screen(PDD-SS),以便快速准确地筛查 PDD。在这项前瞻性研究中,纳入了 70 名非痴呆(年龄 73.8 +/- 4.4)和 32 名痴呆(年龄 73.8 +/- 4.4)的定期就诊于运动障碍诊所的 PD 患者。痴呆的诊断基于 DSM-IV 标准、CDR 评分≥1 和 PD-CRS 总分<64。对所有参与者进行了 PDD-SS、Mattis 痴呆评定量表(MDRS)和简易精神状态检查(MMSE)。检查了 PDD-SS 的有效性、可靠性和区分能力。该量表的最终版本包括即时和延迟言语记忆、画钟、交替言语流畅性以及涵盖常见于 PDD 的认知和精神症状(幻觉、冷漠)的问卷。PDD-SS 的截断值<11 对诊断 PDD 具有很高的敏感性(89.8%)和特异性(88.5%)。MDRS 显示出类似的准确性,但 PDD-SS 的给药时间明显更短(4.8-6.9 分钟对 17.5-25.2 分钟)。使用 PDD-SS 诊断痴呆不受年龄、教育程度或运动功能的影响。PDD-SS 似乎是第一个用于诊断 PDD 的 BST,具有出色的诊断准确性,给药时间为 5 到 7 分钟。

相似文献

1
PDD-Short Screen: a brief cognitive test for screening dementia in Parkinson's disease.简易认知测试 PDD-Short Screen:用于帕金森病患者痴呆筛查的简易认知测试。
Mov Disord. 2010 Mar 15;25(4):440-6. doi: 10.1002/mds.22877.
2
Cut-off score of the Mattis Dementia Rating Scale for screening dementia in Parkinson's disease.用于帕金森病痴呆筛查的马蒂斯痴呆评定量表的临界值。
Mov Disord. 2008 Aug 15;23(11):1546-50. doi: 10.1002/mds.22173.
3
Sensitivity and specificity of Addenbrooke's Cognitive Examination, Mattis Dementia Rating Scale, Frontal Assessment Battery and Mini Mental State Examination for diagnosing dementia in Parkinson's disease.简易智能精神状态检查、马特斯痴呆评定量表、额叶评估量表和简易精神状态检查在帕金森病患者痴呆诊断中的敏感性和特异性。
Parkinsonism Relat Disord. 2012 Jun;18(5):553-6. doi: 10.1016/j.parkreldis.2012.02.010. Epub 2012 Mar 8.
4
[Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].[简短认知功能测试组合(B2C)的验证。在精神科实践中筛查阿尔茨海默病和抑郁症的价值]
Encephale. 2003 May-Jun;29(3 Pt 1):266-72.
5
Cognitive impairment in Parkinson's disease: tools for diagnosis and assessment.帕金森病中的认知障碍:诊断与评估工具
Mov Disord. 2009 Jun 15;24(8):1103-10. doi: 10.1002/mds.22506.
6
Evaluation of doctor/patient satisfaction with the use of the Parkinson's Disease Dementia-Short-Screen (PDD-SS): a screening test for dementia in Parkinson's disease (DIFFUSION study).评价医生/患者对帕金森病痴呆-短筛检表(PDD-SS)的使用满意度:帕金森病痴呆的筛查测试(DIFFUSION 研究)。
Neurologia. 2011 Oct;26(8):461-7. doi: 10.1016/j.nrl.2011.03.013. Epub 2011 May 28.
7
Executive dysfunction in non-demented Parkinson's disease patients with hallucinations.非痴呆帕金森病幻觉患者的执行功能障碍
Acta Neurol Scand. 2008 Apr;117(4):255-9. doi: 10.1111/j.1600-0404.2007.00933.x. Epub 2007 Oct 8.
8
The Clock Drawing Test for dementia of the Alzheimer's type: A comparison of three scoring methods in a memory disorders clinic.阿尔茨海默病型痴呆的画钟测试:记忆障碍门诊中三种评分方法的比较
Int J Geriatr Psychiatry. 1997 Jun;12(6):619-27.
9
Neuropsychiatric disturbances in Parkinson's disease clusters in five groups with different prevalence of dementia.帕金森病中的神经精神障碍分为五组,痴呆患病率各不相同。
Acta Psychiatr Scand. 2005 Sep;112(3):201-7. doi: 10.1111/j.1600-0447.2005.00562.x.
10
Dementia associated with Parkinson's disease: applying the Movement Disorder Society Task Force criteria.帕金森病相关痴呆:应用运动障碍学会工作组标准。
Parkinsonism Relat Disord. 2011 Sep;17(8):621-4. doi: 10.1016/j.parkreldis.2011.05.017. Epub 2011 Jun 30.

引用本文的文献

1
Cognitive dysfunction in animal models of human lewy-body dementia.人类路易体痴呆动物模型中的认知功能障碍。
Front Aging Neurosci. 2024 Jul 22;16:1369733. doi: 10.3389/fnagi.2024.1369733. eCollection 2024.
2
Association of the serum microRNA-29 family with cognitive impairment in Parkinson's disease.血清 microRNA-29 家族与帕金森病认知障碍的关联。
Aging (Albany NY). 2020 Jul 9;12(13):13518-13528. doi: 10.18632/aging.103458.
3
Parkinson's Disease: Cognitive Impairment.帕金森病:认知障碍
Focus (Am Psychiatr Publ). 2017 Jan;15(1):42-54. doi: 10.1176/appi.focus.20160043. Epub 2017 Jan 11.
4
Genetic factors influencing frontostriatal dysfunction and the development of dementia in Parkinson's disease.影响帕金森病额颞叶功能障碍及痴呆症发展的遗传因素。
PLoS One. 2017 Apr 11;12(4):e0175560. doi: 10.1371/journal.pone.0175560. eCollection 2017.
5
GBA Variants Influence Motor and Non-Motor Features of Parkinson's Disease.GBA基因变异影响帕金森病的运动和非运动特征。
PLoS One. 2016 Dec 28;11(12):e0167749. doi: 10.1371/journal.pone.0167749. eCollection 2016.
6
Clinical Epidemiology, Evaluation, and Management of Dementia in Parkinson Disease.帕金森病痴呆的临床流行病学、评估与管理
Am J Alzheimers Dis Other Demen. 2016 Nov;31(7):585-594. doi: 10.1177/1533317516653823. Epub 2016 Jun 13.
7
Insula Volume and Salience Network Are Associated with Memory Decline in Parkinson Disease: Complementary Analyses of Voxel-Based Morphometry versus Volume of Interest.脑岛体积与突显网络与帕金森病的记忆衰退相关:基于体素的形态测量法与感兴趣体积的互补分析
Parkinsons Dis. 2016;2016:2939528. doi: 10.1155/2016/2939528. Epub 2016 Feb 21.
8
Rational pharmacological approaches for cognitive dysfunction and depression in Parkinson's disease.帕金森病认知功能障碍和抑郁的合理药理学治疗方法。
Front Neurol. 2015 Mar 31;6:71. doi: 10.3389/fneur.2015.00071. eCollection 2015.
9
Cognitive screening in persons with chronic diseases in primary care: challenges and recommendations for practice.基层医疗中慢性病患者的认知筛查:实践中的挑战与建议
Am J Alzheimers Dis Other Demen. 2015 Sep;30(6):547-58. doi: 10.1177/1533317515577127.
10
A recommended scale for cognitive screening in clinical trials of Parkinson's disease.推荐用于帕金森病临床试验中的认知筛查量表。
Mov Disord. 2010 Nov 15;25(15):2501-7. doi: 10.1002/mds.23362.